INAI orders Cofepris to publish information on counterfeit medicines

INAI orders Cofepris to publish information on counterfeit medicines

Mexico City, The Federal Commission for the Protection against Health Risks (Cofepris) must publish information on the 10 medicines with the most complaints for falsification and the number of health complaints in this matter. This was determined by the National Institute of Transparency, Access to Information and Protection of Personal Data (INAI), after resolving the … Read more

They ask Cofepris to support the arrival of anticovid vaccines

They ask Cofepris to support the arrival of anticovid vaccines

The Mexican Association for Pharmaceutical Innovation Industries (AMIIF) made an urgent call for the Mexican health regulator, Cofepris, to grant approval so that updated vaccines for protection against Covid19 and against seasonal flu enter Mexico . Likewise, for the dengue vaccine, which is also urgently needed due to the events in Guerrero and other places … Read more

Cofepris authorizes study for HIV treatment in trans women

Cofepris authorizes study for HIV treatment in trans women

Mexico City. The Federal Commission for the Protection against Health Risks (Cofepris) authorized an innovative clinical trial to evaluate the interaction between gender affirmation therapy and treatments against the human immunodeficiency virus (HIV). The research protocol will examine how estradiol (female sex hormone) relates to three therapeutic combinations for HIV: bictegravir/tenofovir/emtricitabine; dolutegravir/tenofovir/emtricitabine (or lamivudine) and … Read more

Cofepris authorizes the marketing of Paxlovid, the drug against covid-19

Cofepris authorizes the marketing of Paxlovid, the drug against covid-19

La Federal Commission for the Protection against Sanitary Risks (Cofepris) authorized this Thursday, August 1, the health registration of Paxlovid (nirmatrelvir/ritonavir)from the Pfizer laboratory, indicated for the treatment of covid-19 in adults who do not require supplemental oxygen and who are at higher risk of progression to severe COVID-19. “The decision is based on the … Read more

Cofepris Authorizes the Use of Paxlovid for the Treatment of COVID-19 in Mexico

Cofepris Authorizes the Use of Paxlovid for the Treatment of COVID-19 in Mexico

The Federal Commission for the Protection against Sanitary Risks (Cofepris) granted health registration to Paxlovid (nirmatrelvir/ritonavir)from the laboratory Pfizer, for the treatment of COVID-19 in adults who do not require supplemental oxygen and are at increased risk of progression to serious illness. Video: Harvey Weinstein Hospitalized for COVID-19 and Double Pneumonia He Committee on New … Read more

Cofepris closes 97 clandestine clinics

Cofepris closes 97 clandestine clinics

Mexico City. The Federal Commission for the Protection against Sanitary Risks (Cofepris) reported that it closed 97 health service establishments that presented serious irregularities or operated clandestinely. “Since 2022, Cofepris has strengthened actions to reduce and mitigate health risks generated by hospital medical care establishments that fail to comply with both the Mexican Official Standard … Read more

Cofepris warns about unlawful sale of erectile dysfunction treatment

Cofepris warns about unlawful sale of erectile dysfunction treatment

Mexico Metropolis. Two batches of the drug Cialis (tadalafil) for the therapy of erectile dysfunction and prostatic hyperplasia had been counterfeit and are being bought illegally within the nation, warned the Federal Fee for the Safety towards Sanitary Dangers (Cofepris). The manufacturing laboratory Eli Lilly reported that it doesn’t know the origin of batches A913777K … Read more

Cofepris owner presents the ‘SISUS’ platform in the US

Cofepris owner presents the ‘SISUS’ platform in the US

Mexico City. On a working tour in the United States, the head of Cofepris, Alejandro Svarch, presented to PAHO the platform of the Comprehensive Substance System (SISUS) and the impact that its application has to regulate substances as chemical precursors. The presentation was made together with representatives of the Secretary of the Navy (Semar), a … Read more

Ensuring Validity of Covid-19 Vaccine Permits: Hidalgo Health Official Urges Population to Verify Cofepris Authorization

Ensuring Validity of Covid-19 Vaccine Permits: Hidalgo Health Official Urges Population to Verify Cofepris Authorization

Given the availability of the Covid-19 vaccine in some pharmacies in the state, Eduardo Bustos Vázquez, deputy director of Epidemiology of the Hidalgo Health Secretariat (SSH), asked the population to verify if they have the permits from the Federal Commission for the Protection against Sanitary Risks (Cofepris), for its commercialization. Bustos Vazquez explained that on … Read more

Cofepris Must Inform Authorization for Pfizer COVID-19 Vaccine Use in Children 5 Years Old: Inai Ruling

Cofepris Must Inform Authorization for Pfizer COVID-19 Vaccine Use in Children 5 Years Old: Inai Ruling

The Federal Commission for the Protection against Health Risks (Cofepris) must inform the authorization for the use of the Pfizer vaccine contra COVID-19 in minors 5 years old. The above, for instruction of the National Institute of Transparency, Access to Information and Protection of Personal Data (Inai). A person requested the resolution by which the … Read more